Last updated on November 2019

Biomarker-based Study in R/M SCCHN

Brief description of study

This is a biomarker-driven trial that will enroll patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing after first-line platinum-based chemotherapy. Based on potential biomarkers and molecular alterations identified in the biopsy from the central platform, patients will be allocated in different cohorts. There will be biomarker-positive patient cohorts and immunotherapy cohorts.

Clinical Study Identifier: NCT03088059

Find a site near you

Start Over